Insilico Medicine alternatives and competitors
The closest alternatives to Insilico Medicine are XtalPi, Iktos, Recursion and Variational AI.
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
10 alternatives to Insilico Medicine
What each product does, with its price as the vendor publishes it.
-
X
XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024.
Price: No published price
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
V
Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile.
Price: Custom project pricing
-
A
Absci designs antibodies with generative AI and develops them as its own medicines and with partners.
Price: No published price
-
V
Valo Health uses AI on large scale human data to find drug targets and design small molecules, through its Opal Computational Platform.
Price: No published price
-
M
Medvolt, based in Pune, India, sells MedGraph, an AI and physics based in silico platform for early drug discovery, to pharmaceutical and biotechnology companies as software modules and as delivered projects.
Price: No published price
-
G
Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature.
Price: Not applicable
-
D
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
Price: No published price
-
I
Clinical stage drug discovery company in San Diego whose platform pairs two named model families with automated laboratories.
Insilico Medicine alternatives, answered
What are the best alternatives to Insilico Medicine?
The closest alternatives to Insilico Medicine are XtalPi, Iktos, Recursion, Variational AI and Absci. XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024. Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016. Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile.
Who are Insilico Medicine's competitors?
Insilico Medicine's competitors in the Drug Discovery AI category include XtalPi, Iktos, Recursion, Variational AI, Absci and Valo Health.